Case Study

How MMS Modernized Pulmonary Data Models to Streamline Clinical Analysis and Improve Decision-Making

Discover a scalable data modeling framework that accelerates analytics, supports regulatory clarity, and enhances insights across complex pulmonary studies.

Pulmonary clinical programs generate large volumes of diverse and complex data—from spirometry and gas exchange outputs to patient questionnaires and longitudinal functional assessments. Without a harmonized and scalable data model, sponsors often struggle with inefficient analyses, inconsistent datasets, and delays in regulatory submissions.

This resource explores how MMS partnered with a sponsor to design and implement a unified Pulmonary Suite Data Model supporting multiple endpoints, cross-study consistency, and downstream statistical efficiency. Built with reusable architecture and long-term scalability, the solution streamlined data processing and ensured reliable, repeatable outputs for regulatory and clinical teams.

Whether you lead biometrics, clinical development, or data standards strategy, this resource demonstrates how modern pulmonary data modeling can improve interpretability, strengthen evidence packages, and reduce operational burden across trials.

Key Benefits / What You’ll Learn:

  • Understand how standardized data models reduce variability and simplify complex pulmonary analyses.
  • Learn how MMS designed a reusable, scalable structure spanning multiple pulmonary endpoints.
  • See how harmonized data outputs accelerate programming, review, and regulatory submission readiness.
  • Discover how integrated models improve traceability, interpretability, and decision-making across studies.

Created by MMS experts in biostatistics, data standards, and clinical analytics with extensive experience supporting respiratory and functional therapeutics.

Access the Pulmonary Suite Data Models Resource

How MMS Modernized Pulmonary Data Models to Streamline Clinical Analysis and Improve Decision-Making
casestudy

How MMS Modernized Pulmonary Data Models to Streamline Clinical Analysis and Improve Decision-Making

Discover a scalable data modeling framework that accelerates analytics, supports regulatory clarity, and enhances insights across complex pulmonary studies.

Suggested For You

case study

July 31st, 2026

Delivering Strategic Biostatistics Support to Enable Phase 2b Funding Decisions

case study

July 8th, 2026

Operating as an Integrated Regulatory Writing and Submission Partner for Small and Mid-Size Pharmaceutical Companies

case study

June 30th, 2026

Turning Regulatory Pressure into a Strategic Partnership: Public Release of Clinical Information (PRCI) for a Large Biotech Organization

case study

December 10th, 2025

From Challenge to Confidence: How MMS Delivered 800+ High-Quality Narratives in Record Time

case study

December 1st, 2025

Expert Support for Regulatory Briefing Books that Strengthen Sponsor Defense Strategies

case study

November 28th, 2025

How MMS Scaled Biostatistics Expertise to Accelerate a High Priority Vaccine Program

case study

November 24th, 2025

Regulatory Expertise that Strengthens Global Market Success

case study

November 19th, 2025

How MMS Supported IDMC Operations to Ensure Integrity and Safety in a High Complexity COVID 19 Trial

case study

November 17th, 2025

Strengthen Early Phase Oncology Trials with Expert Biostatistical Support

case study

November 14th, 2025

Transforming Real-World Data into Regulatory-Ready Evidence with KerusCloud®

case study

November 12th, 2025

How One Sponsor Rescued an Underpowered Trial Using Simulation-Guided Design

case study

November 10th, 2025

Evaluating Biomarkers with KerusCloud®: Powering Precision in Early Clinical Decision-Making